Molecular pathophysiology of Parkinson's disease
Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that
results primarily from the death of dopaminergic neurons in the substantia nigra. Although …
results primarily from the death of dopaminergic neurons in the substantia nigra. Although …
The genetic epidemiology of neurodegenerative disease
Gene defects play a major role in the pathogenesis of degenerative disorders of the nervous
system. In fact, it has been the very knowledge gained from genetic studies that has allowed …
system. In fact, it has been the very knowledge gained from genetic studies that has allowed …
High-resolution whole-genome association study of Parkinson disease
DM Maraganore, M De Andrade, TG Lesnick… - The American Journal of …, 2005 - cell.com
We performed a two-tiered, whole-genome association study of Parkinson disease (PD). For
tier 1, we individually genotyped 198,345 uniformly spaced and informative single …
tier 1, we individually genotyped 198,345 uniformly spaced and informative single …
Genetics of Parkinson's disease
T Gasser - Current opinion in neurology, 2005 - journals.lww.com
Genetics of Parkinson's disease : Current Opinion in Neurology Genetics of Parkinson's
disease : Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe Get …
disease : Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe Get …
[HTML][HTML] Phosphorylated tau and the neurodegenerative foldopathies
Many studies have implicated phosphorylated tau in the Alzheimer disease process.
However, the cellular fate of phosphorylated tau has only recently been described. Recent …
However, the cellular fate of phosphorylated tau has only recently been described. Recent …
Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease
GD Mellick, DM Maraganore, PA Silburn - Neuroscience letters, 2005 - Elsevier
It remains unclear whether genetic variants in SNCA (the alpha-synuclein gene) alter risk for
sporadic Parkinson's disease (PD). The polymorphic mixed sequence repeat (NACP-Rep1) …
sporadic Parkinson's disease (PD). The polymorphic mixed sequence repeat (NACP-Rep1) …
Mitochondrial microheteroplasmy and a theory of aging and age-related disease
RM Smigrodzki, SM Khan - Rejuvenation research, 2005 - liebertpub.com
We implicate a recently described form of mitochondrial mutation, mitochondrial
microheteroplasmy, as a candidate for the principal component of aging. Microheteroplasmy …
microheteroplasmy, as a candidate for the principal component of aging. Microheteroplasmy …
Molecular genetic pathways in Parkinson's disease: a review
S Jain, NW Wood, DG Healy - Clinical Science, 2005 - portlandpress.com
Major progress has been made in the last decade in understanding the genetic basis of PD
(Parkinson's disease) with five genes unequivocally associated with disease. As a result …
(Parkinson's disease) with five genes unequivocally associated with disease. As a result …
UCHL1 is associated with Parkinson's disease: a case-unaffected sibling and case-unrelated control study
M Facheris, KJ Strain, TG Lesnick, M De Andrade… - Neuroscience …, 2005 - Elsevier
To avoid the possible confounding effect of population stratification, we employed a
discordant sibling study design and a liberalization of the sibling transmission disequilibrium …
discordant sibling study design and a liberalization of the sibling transmission disequilibrium …
Genetic association analysis: lessons from the study of Alzheimers disease
AJ Brookes, JA Prince - Mutation Research/Fundamental and Molecular …, 2005 - Elsevier
Association studies are an increasingly popular way to test single nucleotide polymorphisms
and other gene sequence variations for their involvement in complex disease. Alzheimers …
and other gene sequence variations for their involvement in complex disease. Alzheimers …